Abstract
Staging of hepatocellular carcinoma (HCC) and other hepatobiliary cancers is critical for optimal treatment and a complex task that depends on multiple factors, such as tumor extent at diagnosis and liver function. In recent years, several staging systems have been developed that have markedly improved the methods to arrive at optimal risk stratification procedures and the formulation of novel treatment approaches. However, still no single staging system is successfully applicable to any patient with hepatobiliary cancer. Apart from HCC, intricate and highly reproducible staging systems have been developed for extrahepatic cholangiocarcinoma, intrahepatic cholangiocarcinoma, and hepatoblastoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adam A, Benjamin IS (1992) The staging of cholangiocarcinoma. Clin Radiol 46:299–303
Aronson DC, Schnater M, Staalman CR, Weverling GJ, Plaschkes J, Perilongo G et al (2005) Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 23:1245–1252
Bengmark S, Ekberg H, Evander A, Klofver-Stahl B, Tranberg KG (1988) Major liver resection for hilar cholangiocarcinoma. Ann Surg 207:120–125
Bismuth H, Corlette MB (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170–178
Blechacz BR, Sanchez W, Gores GJ (2009) A conceptual proposal for staging ductal cholangiocarcinoma. Curr Opin Gastroenterol 25:238–239
Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8:512–522
Bolondi L, Burroughs A, Dufour JF, Galle PR, Mazzaferro V, Piscaglia F, Raoul JL et al (2012) Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis 32:348–359
Burns JM, Greene FL (2005) Controversies in staging of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 12:456–462
Chan AC, Fan ST, Poon RT, Cheung TT, Chok KS, Chan SC, Lo CM (2013) Evaluation of the seventh edition of the American Joint Committee on cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system. HPB (Oxford) 15:439–448
Cheng CH, Lee CF, Wu TH, Chan KM, Chou HS, Wu TJ, Yu MC, Chen TC, Lee WC et al (2011) Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma. World J Surg Oncol 9:114
Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C (1999) A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d’Etude et de Traitement du Carcinoma Hépatocellulaire. J Hepatol 31:133–141
Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16:3048–3056
Chun YH, Ahn SH (2011) Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer 47:2568–2575
Chun JM, Kwon HJ, Sohn J, Kim SG, Park JY, Bae HI, Yun YK, Hwang YJ (2011) Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. J Surg Oncol 103:148–151
Chung YE, Kim MJ, Park YN, Lee YH, Choi JY (2008) Staging of extrahepatic cholangiocarcinoma. Eur Radiol 18:2182–2195
Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, Neri D, Boccagni P et al (2006) Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 44:723–731
DeOliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, Clavien PA (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53:1363–1371
Ebata T, Nagino M, Nishio H, Igami T, Yokoyama Y, Nimura Y (2007) Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer. World J Surg 31:2008–2015
Edge SB (2009) American Joint Committee on Cancer: AJCC cancer staging manual, 7th edn. Springer, New York
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D’Angelica M, DeMatteo RP et al (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248:84–96
Farges O, Fuks D, Le Treut YP, Azoulay D, Laurent A, Bachellier P, Nuzzo G, Belghiti J et al (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer 117:2170–2177
Hasebe T, Konishi M, Iwasaki M, Nakagohri T, Takahashi SI, Gotohda N, Kinoshita T, Ochiai A (2008) Primary tumor/vessel tumor/nodal tumor classification of extrahepatic bile duct carcinoma. Hum Pathol 39:37–48
Hiriart JB, Laurent C, Blanc JF (2011) Perihilar cholangiocarcinoma, the need for a new staging system. Clin Res Hepatol Gastroenterol 35:697–698
Hong SM, Kang GH, Lee HY, Ro JY (2000) Smooth muscle distribution in the extrahepatic bile duct: histologic and immunohistochemical studies of 122 cases. Am J Surg Pathol 24:660–667
Hsu CY, Huang YH, Hsia CY, Su CW, Lin HC, Loong CC, Chiou YY, Chiang JH et al (2010) A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System. J Hepatol 53:108–117
Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee HS, Lin PW, Huang GT et al (2005) Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 20:765–771
Huang J, Zhang Y, Peng Z, Gao H, Xu L, Jiao LR, Chen M (2013) A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy. J Cancer Res Clin Oncol 139:1709–1719
Huo TI, Huang YH, Lin HC, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD (2006) Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy. Am J Gastroenterol 101:975–982
Igami T, Ebata T, Yokoyama Y, Sugawara G, Takahashi Y, Nagino M (2011) Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications. World J Surg 35:2501–2509
Japanese Society of Biliary Surgery (1997) General rules for surgical and pathological studies on cancer of biliary tract, 4th edn. Kanehara, Tokyo
Jarnagin WR (2000) Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 19:156–176
Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–519
Juntermanns B, Sotiropoulos GC, Radunz S, Reis H, Heuer M, Baba HA, Canbay A et al (2013) Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinoma. Ann Surg Oncol 20:277–284
Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, Abdalla EK, Vauthey JN et al (2011a) Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol 29:3892–3899
Kaseb AO, Abbruzzese JL, Vauthey JN, Aloia TA, Abdalla EK, Hassan MM, Lin E et al (2011b) I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score. Oncology 80:373–381
Kee KM, Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH, Cheng YF, Hsu HC et al (2007) Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer 120:2650–2655
Kim HJ (2005) TNM staging of hilar cholangiocarcinoma (in Korean). Korean J Gastroenterol 46:20–27
Kim BK, Kim SU, Park JY, Kim do Y, Ahn SH, Park MS, Kim EH, Seong J, Lee do Y et al (2012) Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma. Liver Int 32:1120–1127
Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H et al (2013) The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma. BMC Cancer 13:52
Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y (2001) Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233:385–392
Koerkamp BG, Wiggers JK, Allen PJ, Busch OR, D’Angelica MI, DeMatteo RP, Fong Y et al (2014) American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. HPB (Oxford) 16:1074–1082
Kokudo N, Arita J (2010) Staging for intrahepatic cholangiocarcinoma. Liver Int 30:931–933
Kudo M, Chung H, Osaki Y (2003) Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38:207–215
Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T (2004) Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 40:1396–1405
Leung TW, Tang AM, Zee B, Lau WY, Lai PB, Leung KL, Lau JT, Yu SC, Johnson PJ (2002) Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 94:1760–1769
Li X, Dong M, Lin Q, Chen ZH, Ma XK, Xing YF, Wan XB, Wen JY, Wei L, Chen J et al (2013) Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials. Asia Pac J Clin Oncol 9:86–92
Liver Cancer Study Group of Japan (1997) Clinical and surgical findings. In: Liver Cancer Study Group of Japan (ed) Classification of primary liver cancer. First English edition. Kanehara Shuppan, Toyko, pp 1–22
Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338
Maida M, Orlando E, Camma C, Cabibbo G (2014) Staging systems of hepatocellular carcinoma: a review of literature. World J Gastroenterol 20:4141–4150
Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS (2005) Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41:707–716
Matsuo K, Rocha FG, Ito K, D’Angelica MI, Allen PJ, Fong Y, Dematteo RP, Gonen M et al (2012) The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 215:343–355
McCarville MB, Roebuck DJ (2012) Diagnosis and staging of hepatoblastoma: imaging aspects. Pediatr Blood Cancer 59:793–799
Meyers RL, Katzenstein HM, Malogolowkin MH (2007) Predictive value of staging systems in hepatoblastoma. J Clin Oncol 25:737
Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH (2009) Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 53:1016–1022
Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M (2007) Staging of hepatocellular carcinoma. Assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245:909–922
Nagino M (2011) Perihilar cholangiocarcinoma: a much needed but imperfect new staging system. Nat Rev Gastroenterol Hepatol 8:252–253
Nanashima et al. (2006) http://www.ncbi.nlm.nih.gov/pubmed/16699859
Nathan H, Pawlik TM (2010) Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 26:269–273
Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, Choti MA et al (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16:14–22
Nishi M, Omori Y, Miwa K (1998) Japanese Research Society for Gastric Cancer (JRSGC): Japanese classification of gastric carcinoma. Kanehara, Tokyo
Nishio H, Nagino M, Oda K, Ebata T, Arai T, Nimura Y (2005) TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system. Langenbecks Arch Surg 390:319–327
No authors (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 28:751–755
Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, Makuuchi M (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383
Okuda K, Ohtsuki T, Obata H, Tamimatsu M, Okazaki N, Hasegawa H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918–928
Omagari K, Honda S, Kadokawa Y, Isomoto H, Takeshima F, Hayashida K, Mizuta Y et al (2004) preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma. J Gastroenterol Hepatol 19:805–811
Paul A, Kaiser GM, Molmenti EP, Schroeder T, Venadakis S, Oezcelik A, Baba HA et al (2011) Klatskin tumors and the accuracy of the Bismuth-Corlette classification. Am Surg 77:1695–1699
Pinato DJ, Stebbing J, Ishizuka M, Khan SA, Wasan HS, North BV, Kubota K, Sharma R (2012) A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). J Hepatol 57:1013–1020
Pons F, Varela M, Llovet JM (2005) Staging systems in hepatocellular carcinoma. HPB (Oxford) 7:35–41
Ribero D, Nuzzo G, Amisano M, Tomatis M, Guglielmi A, Giulini SM, Aldrighetti L et al (2011) Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma. HPB (Oxford) 13:198–205
Roebuck DJ, Olsen O, Pariente D (2006) Radiological staging in children with hepatoblastoma. Pediatr Radiol 36:176–182
Roebuck DJ, Aronson D, Clapuyt P, Czauderna P, de Ville de Goyet J, Gauthier F et al (2007a) 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 37:123–132
Roebuck DJ, Sebire NJ, Pariente D (2007b) Assessment of extrahepatic abdominal extension in primary malignant liver tumours of childhood. Pediatr Radiol 37:1096–1100
Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie F, Sui CJ, Yang JM (2009) Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 15:5976–5982
Sobin LH, Wittekin C (1997) UICC TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York
Sobin LH, Gospodarowicz MK, Wittekind C (2009a) International union against cancer (UICC) TNM classification of malignant tumours, 7th edn. Wiley, New York
Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2009b) TNM classification of malignant tumours, 7th edn. UICC, International Union against Cancer, Wiley-Blackwell, Oxford
Tateishi R, Yoshida H, Shiina S, Imamura H, Hasegawa K, Teratani T, Obi S, Sato S et al (2005) Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 54:419–425
Tsunoda T, Eto T, Koga M, Tomioka T, Motoshima K, Yamaguchi T, Izawa K, Tsuchiya R (1989) Early carcinoma of the extrahepatic bile duct. Jpn J Surg 19:691–698
Uchiyama K, Yamamoto M, Yamaue H, Ariizumi S, Aoki T, Kokudo N, Ebata T, Nagino M et al (2011) Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Surg 18:443–452
Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, Hai S, Kubo S (2005) Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 12:479–483
Uenishi T, Ariizumi S, Aoki T, Ebata T, Ohtsuka M, Tanaka E, Yoshida H, Imura S et al (2014) Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 21:499–508
Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM et al (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20:1527–1536
Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, Brouquet A et al (2010) Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12:289–299
Vitale et al. (2011) http://www.ncbi.nlm.nih.gov/pubmed/21912636
Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL et al (2010) Protocol for the examination of specimens from patients with carcinoma of the distal extrahepatic bile ducts. Arch Pathol Lab Med 134:e8–e13
Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH (2001) Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 193:384–391
Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10:288–291
Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT (2014) Development of Hong Kong Liver Cancer Staging System with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology 146:1691–1700
Yi J, Gwak GY, Sinn DH, Kim YJ, Kim HN, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC (2013) Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1. Hepatogastroenterology 60:328–332
Zhang JF, Shu ZJ, Xie CY, Li Q, Jin XH, Gu W, Jiang FJ, Ling CQ (2014) Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUOPI, JIS, CIS) in a Chinese cohort. PLoS One 9:e88182
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Zimmermann, A. (2017). Staging of Hepatocellular Carcinoma, Hepatoblastoma, and Cholangiocarcinomas. In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-26956-6_188
Download citation
DOI: https://doi.org/10.1007/978-3-319-26956-6_188
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26954-2
Online ISBN: 978-3-319-26956-6
eBook Packages: MedicineReference Module Medicine